A double-blind comparative trial of remo
β
R. Deo; S. Soni; S. C. Rastogi; S. Levine; I. Plant; J. Guy Edwards; M. J. Mitch
π
Article
π
1990
π
John Wiley and Sons
π
English
β 577 KB
A multicentre parallel group study was carried out to compare the efficacy and safety of remoxipride, a new antipsychotic drug, with haloperidol in the treatment of acute schizophrenia. Patients were randomly assigned to the two groups and assessments were made under double-blind conditions. Treatme